Primatene Mist Availability Not “Essential,” Advisory Panel Says

Questions about the appropriateness of asthma for OTC treatment led to an FDA advisory panel vote in favor of removing Wyeth's Primatene Mistfrom the market during a Jan. 24 meeting in Bethesda, Md